Key points are not available for this paper at this time.
Administration of JAK2 inhibitor resulted in deterioration of myocardial viability in AMI hearts. The JAK/STAT pathway is activated in AMI myocardium and plays a pivotal role in cytoprotective signaling.
Shigeru Negoro (Fri,) studied this question.